Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/10/2009CA2280612C Amino acid-sugar composition
11/10/2009CA2251027C Defective viral vaccine particles obtained in vivo or ex vivo
11/10/2009CA2186953C Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
11/09/2009CA2631071A1 Inhibition of calpain reduces allergic inflammation
11/05/2009WO2009135184A2 Methods for treating and/or preventing cardiomyopathies by erk or jnk inhibition
11/05/2009WO2009135135A2 Fibromodulin formulation for reducing corneal scarring
11/05/2009WO2009135091A1 Use of asenapine and related compounds for the treatment of neuronal or non-neuronal diseases or conditions
11/05/2009WO2009135067A1 Pharmaceutical polish formulations
11/05/2009WO2009135000A2 Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-117199 and analogs
11/05/2009WO2009134995A2 Tetrazole compounds for reducing uric acid
11/05/2009WO2009134973A1 Quenolines and related analogs as sirtuin modulators
11/05/2009WO2009134967A2 Use of nucleic acids with reduced pressure therapy
11/05/2009WO2009134948A1 Methods and kits for the treatment of inflammatory bowel disorder conditions
11/05/2009WO2009134947A1 Nicotine lozenge compositions
11/05/2009WO2009134938A1 Indoline anti-cancer agents
11/05/2009WO2009134877A2 Therapeutics for treatment resistant mental disorders
11/05/2009WO2009134870A1 Potent cell-binding agent drug conjugates
11/05/2009WO2009134856A2 Pharmaceutical gallium compositions and methods
11/05/2009WO2009134850A1 Prolyl hydroxylase inhibitors
11/05/2009WO2009134847A1 Prolyl hydroxylase inhibitors
11/05/2009WO2009134825A1 Metal complex phosphatidyl-inositol-3-kinase inhibitors
11/05/2009WO2009134754A1 Benzoimidazole glycinamides as prolyl hydroxylase inhibitors
11/05/2009WO2009134750A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009WO2009134741A1 Dual-acting antihypertensive agents
11/05/2009WO2009134726A1 Substituted pyrimidine derivatives as histamine h4 receptor ligands
11/05/2009WO2009134725A2 Compositions and methods for treating progesterone-dependent conditions
11/05/2009WO2009134723A1 Pregesteron antagonists such as cdb-4124 in the treatment of breast cancer
11/05/2009WO2009134718A1 Pregesteron antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
11/05/2009WO2009134713A1 Compositions and methods for male contraception
11/05/2009WO2009134666A1 Indazole compounds as ccr1 receptor antagonists
11/05/2009WO2009134658A2 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009WO2009134637A1 Piperazine-based ccr5 antagonist tablet dosage form
11/05/2009WO2009134624A1 Hcv ns3 protease inhibitors
11/05/2009WO2009134617A1 Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
11/05/2009WO2009134616A2 Novel inhibitors of hepatitis c virus replication
11/05/2009WO2009134574A2 Disubstituted phthalazine hedgehog pathway antagonists
11/05/2009WO2009134524A2 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
11/05/2009WO2009134511A1 Topical compositions for improving appearance of keratinous surfaces
11/05/2009WO2009134460A1 Methods of treatment using ammonia-scavenging drugs
11/05/2009WO2009134404A2 Steroidal compounds as melanogenesis modifiers and uses thereof
11/05/2009WO2009134400A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134392A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134387A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134384A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134383A2 Vinyl substituted fatty acids
11/05/2009WO2009134347A2 Sulfoalkyl ether cyclodextrin compositions
11/05/2009WO2009134336A1 Novel formulations for treatment of migraine
11/05/2009WO2009134279A1 Tubulysin d analogues
11/05/2009WO2009134224A1 Synergistic pesticidal mixtures
11/05/2009WO2009134203A1 New peptidomimetic compounds
11/05/2009WO2009134147A1 Lipid compositions containing derivatives of epa and dha an their use thereof
11/05/2009WO2009134110A1 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof
11/05/2009WO2009133970A1 Crystalline compound
11/05/2009WO2009133968A1 Charge conversional ternary polyplex
11/05/2009WO2009133964A1 Agent for prevention of oxidative stress
11/05/2009WO2009133963A1 Methods of administering antitumor agent comprising deoxycytidine derivative
11/05/2009WO2009133940A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009WO2009133863A1 Immunopotentiating agent comprising ep1 agonist
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009133834A1 Keto-amide derivative having inhibitory activity on endothelial lipase
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009133701A1 Phenylimidazole derivative and therepeutic and/or prophylactic agent for retinal/choroidal disorder
11/05/2009WO2009133692A1 Quinoline compound
11/05/2009WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009WO2009133686A1 Medicaments for treating alzheimer's disease
11/05/2009WO2009133647A1 Polymerized cyclic nitroxide radical compound, and use thereof
11/05/2009WO2009133637A1 Sheet preparation for external use and sheet preparation set for external use
11/05/2009WO2009133618A1 Hyperthermic apoptotic enhancing activator containing benzocyclobutene derivative
11/05/2009WO2009133616A1 Versatile disinfectant
11/05/2009WO2009133586A1 Remedy for alzheimer's disease
11/05/2009WO2009133560A1 Non-hydrolyzable and permeable cyclic bis-[nucleotide monophosphate] derivatives and uses thereof
11/05/2009WO2009133522A1 Piperidine and pyrrolidine compounds
11/05/2009WO2009133470A2 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration
11/05/2009WO2009133458A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
11/05/2009WO2009133442A1 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors
11/05/2009WO2009133431A1 Oral liquid compositions of rhein or diacerein
11/05/2009WO2009133430A1 Topical compositions of rhein or diacerein
11/05/2009WO2009133387A1 Indole- 3 -glyoxylamide derivatives for use as calcium ion channel modulators
11/05/2009WO2009133352A2 Lipid composition
11/05/2009WO2009133348A1 Aminopyridine derivatives
11/05/2009WO2009133325A2 Polymerized micelles
11/05/2009WO2009133314A1 1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
11/05/2009WO2009133310A2 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
11/05/2009WO2009133294A2 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules
11/05/2009WO2009133278A1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest
11/05/2009WO2009133269A1 Novel diomestine derivatives, method for preparing same and pharmaceutical compositions containing same
11/05/2009WO2009133180A1 Nicardipine hydrochloride dihydrate and chloroformate
11/05/2009WO2009133147A1 Novel triazole derivatives, their preparation and their application in therapeutics
11/05/2009WO2009133140A1 Biological method for in vivo tracking of molecules affecting cellular migration
11/05/2009WO2009133136A1 Compounds
11/05/2009WO2009133128A1 Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
11/05/2009WO2009133127A1 Fused bicyclic compounds and use thereof as pi3k inhibitors
11/05/2009WO2009133110A1 Modulators of dopamine neurotransmission
11/05/2009WO2009133109A1 Modulators of dopamine neurotransmission
11/05/2009WO2009133107A1 Modulators of dopamine neurotransmission
11/05/2009WO2009133097A1 Preparation of n-6 demethylated, 9-10-dihydrolysergic acid alkyl esters
11/05/2009WO2009133089A1 Improved statin production
11/05/2009WO2009133071A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/05/2009WO2009133070A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/05/2009WO2009133052A1 Benzocycloheptane and benzoxepine derivatives
1 ... 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 ... 7860